Search
PEAR THERAPEUTICS' CUTS ARE NOT ENOUGH; ‘STRATEGIC ALTERNATIVES' AMONG NEXT STEPS
Pear Therapeutics isn't meeting the commercialization goals for its prescription digital therapeutics, so it's now seeking strategic...
CONNECT BIOPHARMA CBP-201 ATOPIC DERMATITIS CHINA PIVOTAL STUDY SHOWED RAPID RELIEF OF PATIENT SYMPTOMS
SAN DIEGO & TAICANG, China & SUZHOU, China--Connect Biopharma Holdings Limited , a global clinical-stage biopharmaceutical company...
SOLUTION TO CLINICAL TRIAL ENROLLMENT LIES HIDDEN IN FDA GUIDANCE
The FDA is apparently open to new technologies that enable patients to easily participate in clinical research, whether it be from...
WHAT ROLE COULD CHATGPT HAVE IN CLINICAL TRIALS? A BIGGER ONE THAN YOU MIGHT THINK
Already, ChatGPT has been named as a co-author on at least four research papers. With proper management, AI generation could be an...
AMBRX RAISES $78 MILLION AND COMPLETES ITS ATM PROGRAM
SAN DIEGO--Ambrx Biopharma Inc., or Ambrx , today announced that it has completed net sales of approximately $78 million of American...
MERCK VACCINES PIPELINE GETS BOOST VIA DEAL FOR OPKO CANDIDATE FOR EPSTEIN-BARR
Merck has licensed global rights to an Opko Health vaccine in development for Epstein-Barr virus. The preclinical vaccine candidate,...
REGEN BIOPHARMA, INC. TO PRESENT AT THE EMERGING GROWTH CONFERENCE ON MARCH 3, 2023
Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts to attend its real-time interactive...
FLAGSHIP STARTUP EMERGES WITH $50M TO SEND DRUGS TO THE RIGHT BIOLOGIC ADDRESS
Ampersand Biomedicines emerged from stealth with technology for site-specific drug delivery that avoids toxic effects throughout the...
POTENTIAL EARNINGS HAVE RATED AMBRX BIOPHARMA A MODERATE BUY
Analysts have recently rated Ambrx Biopharma, Inc a Moderate Buy, even though its $8.50 price target represents a 33% downside. While...
DENOVO BIOPHARMA CREATES INNOVATIVE GENE REGISTRY PROGRAM TO SUPPORT THE FIRST PRECISION MEDICINE FOR TREATMENT RESISTANT DEPRESSION
SAN DIEGO, March 6, 2023 /PRNewswire/ - Denovo Biopharma LLC , a pioneer in applying precision medicine to the development of innovative...
AMBRX TO COMMENCE TRADING ON NASDAQ
SAN DIEGO--Ambrx Biopharma Inc. today announced that it will voluntarily transfer its stock exchange listing to the Nasdaq Stock Market...
AIMING FOR AN EPIGENETICS EDGE, CHROMA RAISES $135M TO MOVE CLOSER TO THE CLINIC
GV led Chroma Medicines Series B financing round, which the biotech will apply toward epigenetic medicines that could offer advantages...
THE DRIVE TO ADOPT DIGITAL THERAPEUTICS: WHERE DO WE STAND?
As regulatory processes and reimbursements are refined, there needs to be a continued focus on how to maximize the benefits for patients...
MANAGER / SENIOR MANAGER CMC PROJECT MANAGEMENT - KINNATE BIOPHARMA INC. - SAN DIEGO, CA
Own and manage SharePoint document repository for maintaining complete and systematic records of executed contracts, reports, and Quality...
REPORT: CLASS-ACTION SECURITIES LAWSUITS DECLINE BUT RISKS REMAIN FOR LIFE-SCIENCES COMPANIES
Disgruntled investors lodged fewer securities claims against life-science companies last year. But when they did sue, investors raised...
ACE-BREAST-02 PIVOTAL PHASE 3 STUDY OF AMBRX'S ARX788 FOR THE TREATMENT OF HER2 POSITIVE METASTATIC BREAST CANCER ACHIEVES POSITIVE RESULTS
SAN DIEGO--Ambrx Biopharma Inc., or Ambrx, announced today that it has been informed by its partner, NovoCodex Biopharmaceuticals,...
REATA PHARMA DRUG WINS FIRST FDA NOD IN ULTRA-RARE NEUROMUSCULAR DISORDER
Skyclarys, a Reata Pharmaceuticals drug, is now approved for treating the rare neuromuscular disorder Friedreich's ataxia. The decision...
DR. REDDY'S EXPANDS IN WOMEN'S HEALTH WITH $90M DEAL FOR MAYNE'S U.S. MEDS
In acquiring Mayne Pharma's U.S. portfolio, Dr. Reddy's gains a birth control pill whose rapid sales growth is attributed to a direct-to-consumer...
HOW PATIENT MONITORING IS POISED TO REVOLUTIONIZE HEALTHCARE
Wearable patient devices can provide healthcare organizations with more varied data, expand options for clinical trials, and make patients...
FDA AUTHORIZES FIRST COVID-19 AND FLU TEST, BUT ITS MAKER FILES FOR BANKRUPTCY
Lucira Health now has the first FDA authorized diagnostic that detects the novel coronavirus and influenza in a single test. But the...